RAD51D and breast cancer: 74 This is now being advocated for unselected (all) women at BC diagnosis.5,74 Panel testing for patients with OC also includes moderate penetrance BC CSGs (eg, RAD51C/RAD51D).75,76 Many more unaffected moderate BC CSG PV carriers will be identified through future cascade testing.